Thailand IVF Hospital Guide: 2025正规医院选择与流程指南
不使用 H1，用样式标题
A 38-year-old woman, with AMH 0.8 ng/mL, FSH 12.6 mIU/mL, and bilateral antral follicle count (AFC) of 4, consulted online in December 2024 about choosing an IVF hospital in Thailand. Her core question was: "My ovarian function has declined. Which hospital in Thailand has more experience with advanced maternal age and poor ovarian response? How long does the specific process take? What is the approximate cost?"
This is a typical "advanced maternal age + poor ovarian response" consultation scenario. In choosing a Thailand IVF hospital, this group needs to focus on the laboratory's embryo culture ability, PGT technology experience, and the doctor's ability to design individualized ovarian stimulation protocols. The following content, based on practical experience, outlines the logic of hospital selection, process milestones, and precautions.
========== 模块 A：问题直接答案 ==========How to Choose a Thailand IVF Hospital
The core logic of choosing a Thailand IVF hospital is "matching," not "ranking." No single hospital is suitable for everyone. Selection should consider the following dimensions:
- Hospital Qualifications and Laboratory Standards — Whether it is ISO 15189 certified, and whether the embryology team is independently established.
- Professional Direction and Experience of the Medical Team — Especially experience with advanced maternal age, poor ovarian response, and recurrent implantation failure.
- Technical Capability of the Embryology Laboratory — Blastocyst culture rate, vitrification thawing survival rate, and PGT (Preimplantation Genetic Testing) platform.
- Experience with Specific Populations — Such as diminished ovarian reserve, male factor, genetic disease carriers, etc.
- Service Process and Communication Efficiency — Whether Chinese language services are provided by medical translators rather than general tour guides.
- Cost Transparency — Whether itemized quotes are provided, and whether packages cover all necessary steps.
Comparison of Main Thailand IVF Hospital Characteristics
| Hospital | Core Characteristics | Target Population |
|---|---|---|
| BNH Hospital | Comprehensive private hospital, high embryology lab standards, extensive PGT experience, equipped with NGS platform | Advanced maternal age, recurrent implantation failure, genetic screening needs |
| Bumrungrad Hospital | Mature international patient service process, multidisciplinary collaboration, can manage complex comorbidities | Those with medical comorbidities requiring multi-specialty consultation |
| Jetanin | Leading in prenatal diagnosis and genetics in Thailand, outstanding PGT-M experience | Single gene disease screening, chromosomal structural abnormalities |
| LRC Fertility Center | Focuses on advanced maternal age and poor ovarian response, individualized stimulation protocol design | Low AMH, diminished ovarian reserve, need for multiple egg retrievals |
| ART Hospital | Outstanding embryo culture technology, stable vitrification thawing survival rate | Need for frozen embryo transfer, long-term embryo storage, male factor |
| EKI Hospital | Advanced laboratory equipment, extensive experience with abnormal sperm quality and azoospermia | Severe oligoasthenoteratozoospermia, need for PESA/TESA sperm retrieval |
Selection Focus for Different Age Groups
Age is a core variable affecting ovarian response and embryo chromosomal normality. The focus of Thailand IVF hospital selection varies significantly by age group:
- Under 35: Ovarian function is usually normal, with a wide range of hospital choices. Focus on embryo culture technology and PGT-A screening capability. Consider centers with higher process efficiency.
- 35–38 years old: Ovarian reserve begins to decline. The hospital needs experience with dynamic AMH and FSH assessment. Focus on individualized ovarian stimulation protocol design. It is recommended to choose a hospital with specific experience in "poor ovarian response."
- 38–42 years old: Risk of chromosomal aneuploidy increases, making PGT-A screening more necessary. Blastocyst culture capability is a key evaluation point. The hospital needs experience managing cycles for advanced maternal age patients.
- Over 42: Ovarian function is significantly reduced. Assess the usability of own eggs. Donor egg options may be needed. Evaluate the hospital's management standards for donor egg resources, focusing on experience with "very low ovarian reserve."
Differences Between Thailand and Other Countries
In the field of assisted reproduction, Thailand, China (mainland), and the United States each have their own positioning in terms of policy, technology, and cost. The following comparison helps understand Thailand's characteristics:
| Dimension | Thailand | China (Mainland) | United States |
|---|---|---|---|
| Legal Policy | Commercial egg and sperm donation restricted, PGT applicable for specific conditions | PGT strictly restricted, long waiting periods for egg/sperm donation | Laws vary by state, surrogacy allowed in some states |
| Technical Standards | Many internationally certified labs, mature embryo culture technology | Standardized technology in top-tier hospitals, but low PGT adoption | Cutting-edge technology, flexible protocols |
| Cost Range | 80,000 – 150,000 RMB (excluding living expenses) | 30,000 – 80,000 RMB | 150,000 – 300,000 RMB |
| Language Communication | Chinese services relatively common, mature medical translation system | No language barrier | Professional medical translation needed |
| Start-up Waiting Time | Cycle can start within 1–3 months | 3–6 months (waiting + tests) | 2–4 months |
Thailand's positioning in assisted reproduction is "mature technology with relatively balanced cost-effectiveness." For those needing PGT screening, advanced maternal age, or declining ovarian function, Thailand strikes a specific balance between technical capability and legal allowances.
========== 模块 F：不同医院差异（深度） ==========In-depth Comparison of Thai Hospitals: Laboratory and Doctor Dimensions
In choosing a Thailand IVF hospital, the following details significantly impact the final outcome and should be confirmed during the initial screening:
1. Laboratory Certification and Team
- Whether it holds ISO 15189 medical laboratory quality system certification.
- Whether the embryology team is in-house or outsourced — an in-house team offers more stable process response and quality control.
- Blastocyst culture success rate data: must be differentiated by age group and embryo source (autologous vs. donor eggs).
2. Doctor Practice Characteristics
- Some doctors practice at multiple hospitals. Confirm the actual consultation time and whether they are consistently at that hospital during the cycle.
- Differences in ovarian stimulation protocol design philosophy: GnRH agonist long protocol, antagonist protocol, PPOS protocol, etc. Different doctors have different preferences and experience with various protocols.
- Depth of experience with specific etiologies like PCOS, endometriosis, and poor ovarian response.
3. Embryo Culture Strategy
- Whether assisted hatching (AH) is routinely performed, especially for frozen or advanced maternal age embryos.
- Blastocyst culture timing: utilization rate differs significantly between Day5 and Day6/7 blastocysts.
- Vitrification technology standards: thawing survival rate should be ≥ 95%.
4. PGT Technology Differences
- Whether it has an NGS (Next Generation Sequencing) platform, rather than only aCGH.
- Embryo biopsy timing: Day5 blastocyst biopsy vs. Day3 cleavage stage biopsy. Blastocyst biopsy has a lower potential impact on the embryo.
- Mosaic embryo management strategy: different hospitals have different reporting methods and transfer recommendations for mosaic ratios.
Easiest Details to Overlook
The following details are often overlooked during the consultation and preparation phase but directly impact process smoothness and final outcome:
- Menstrual Cycle Synchronization: Ovarian stimulation usually starts on day 2–3 of the menstrual cycle. Confirm in advance whether the hospital accepts a "flexible start" or requires a "preparation cycle" (e.g., oral contraceptive pretreatment).
- Recognition of Test Results: Some Thai hospitals accept test reports from Chinese top-tier hospitals within 3 months, but chromosome karyotype analysis and infectious disease screening (HIV, Hepatitis B, Hepatitis C, Syphilis) may need retesting. Basic endocrine tests like AMH, FSH, LH, E2 are recommended on day 2–3 of the menstrual cycle.
- Embryo Storage and Transport: If planning to bring embryos back to China, confirm if the hospital supports "frozen embryo transport." Transport requires specialized cold chain logistics, costing approximately 5,000–10,000 RMB. The receiving hospital in China must have the capability to thaw vitrified embryos.
- Professionalism of Medical Translation: General translators are not familiar with reproductive medical terminology. Ensure accurate translation for key steps (stimulation protocol discussion, consent forms for egg retrieval/transfer). It is recommended to request a translator with a background in assisted reproductive medicine.
- Passport Validity: Passport validity must be ≥ 6 months, otherwise it may affect the processing time for a medical visa.
Easiest Pitfalls to Avoid
Based on feedback from actual cases, the following pitfalls occur frequently and should be avoided in advance:
- "Success Rate" Data Trap: Some hospitals publish "success rates" without differentiating by age group or etiology. The difference between "clinical pregnancy rate" and "live birth rate" can be 15–20%. Request live birth rate data "stratified by age and differentiated by embryo transfer type."
- Package Trap: "All-inclusive packages" usually do not cover PGT costs, medication costs, or multiple egg retrieval costs. The brand and dosage of stimulation medications in the package may be fixed, preventing individualized adjustment based on follicular response. If the cycle is cancelled, refund conditions should be confirmed in writing in advance.
- Difference Between Remote Consultation and In-person Visit: In some organizations, remote consultations are conducted by a "medical consultant" rather than the doctor themselves. The protocol may change completely after meeting the attending doctor in person. It is recommended to require that "remote consultation must be conducted by the attending doctor themselves" and keep records of the consultation.
- Time Planning Mistakes: Ignoring the "preparation cycle" can extend the overall time by 1–2 months; not matching the visa validity period with the treatment cycle; not reserving time for embryo culture + PGT result waiting (usually 3–4 weeks).
Actual Thailand IVF Process
The following is the standard process. Details may vary slightly between hospitals, but the overall framework is consistent:
Phase 1: Preparation in Home Country (1–2 months)
- Complete basic fertility tests: AMH, FSH, LH, E2, P, T, PRL (blood draw on day 2–3 of menstrual cycle).
- Male semen analysis: 2 samples, 2–4 weeks apart.
- Chromosome karyotype analysis (both partners).
- Infectious disease screening (both partners): HIV, Hepatitis B, Hepatitis C, Syphilis, TORCH.
- Uterine cavity assessment (if needed): Hysteroscopy or 3D ultrasound.
- Passport application (if not already done): Validity must be > 6 months.
Phase 2: Remote Initial Consultation and Protocol Determination (2–4 weeks)
- Submit all test reports to the hospital.
- Doctor conducts remote assessment and determines the initial ovarian stimulation protocol.
- Confirm travel date to Thailand, apply for a medical visa (usually takes 7–15 working days).
Phase 3: Travel to Thailand for Ovarian Stimulation (12–14 days)
- Notify the hospital on day 1 of the menstrual cycle.
- Arrive in Thailand on day 2–3 of the menstrual cycle for ultrasound + blood test.
- Start ovarian stimulation: usually 8–12 days, with follicle development monitoring every 1–2 days.
- Trigger ovulation: HCG or GnRH agonist.
- Egg retrieval surgery: 34–36 hours after trigger, under general or local anesthesia.
Phase 4: Embryo Culture and PGT (3–5 weeks)
- Day 1 after retrieval: Observe fertilization.
- Day 3: Cleavage stage embryo assessment.
- Day 5–6: Blastocyst culture and biopsy.
- PGT-A / PGT-M testing: NGS platform, usually takes 2–3 weeks.
- Embryo cryopreservation (vitrification).
Phase 5: Transfer Preparation (1–2 months)
- Prepare the transfer cycle based on endometrial condition: natural cycle or hormone replacement cycle.
- Schedule transfer when the endometrium reaches 7–12 mm with good morphology.
- Luteal phase support after transfer (oral + vaginal medication or injection).
Phase 6: Post-Transfer Management (2 weeks)
- Blood test for HCG 12–14 days after transfer.
- If HCG positive, check for doubling 48 hours later.
- Ultrasound 4 weeks after transfer to confirm intrauterine pregnancy.
Cost Influencing Factors
The cost of Thailand IVF mainly consists of the following items, with significant individual variation:
| Cost Item | Cost Range (RMB) | Influencing Factors |
|---|---|---|
| Ovarian Stimulation Medications | 15,000 – 30,000 | Domestic/imported, dosage, brand (Gonal-f, Puregon, etc.) |
| Egg Retrieval Surgery | 20,000 – 40,000 | Hospital pricing, anesthesia type, need for ultrasound guidance |
| Embryo Culture | 15,000 – 25,000 | Culture duration, assisted hatching, time-lapse imaging |
| PGT-A Screening | 20,000 – 40,000 (per embryo) | Number of embryos screened, technology platform (NGS vs aCGH) |
| Embryo Transfer Surgery | 15,000 – 25,000 | Number of transfers, use of assisted techniques |
| Medication Costs (Luteal Support, etc.) | 5,000 – 15,000 | Medication protocol, treatment duration |
| Total Cost (Excluding Living Expenses) | 80,000 – 150,000 | Hospital choice, individual protocol, number of cycles |
It is important to note: if multiple egg retrievals are needed to accumulate embryos, the total cost will increase exponentially; PGT-M (single gene disease screening) costs more than PGT-A; embryo cryopreservation fees are usually calculated annually, around 2,000–5,000 RMB/year; living expenses (accommodation, food, translation, transportation) are approximately 5,000–10,000 RMB/month.
========== 结尾：风险提醒 ==========Although Thailand IVF technology is mature, the following risks should still be noted: Ovarian Hyperstimulation Syndrome (OHSS) may occur during ovarian stimulation, especially in PCOS patients; egg retrieval surgery carries risks of infection, bleeding, and organ damage (incidence rate about 0.1–0.5%); embryo culture may fail entirely, resulting in no transferable embryos; after PGT screening, there may be no euploid embryos; implantation failure or biochemical pregnancy may occur after transfer; Thai medical visa policies may change, requiring attention to the latest entry requirements; there is a risk of loss during frozen embryo transport.
It is recommended to fully communicate your personal situation with the attending physician before starting the cycle, develop a personalized plan, and prepare a risk contingency plan. All decisions should be based on your own fertility assessment results and medical advice to avoid decision-making bias due to information asymmetry.
Can I do overseas IVF with low AMH? Advanced maternal age IVF preparation Overseas IVF test timing Overseas IVF passport validity Overseas IVF file preparation materials Pre-IVF conditioning Male examination items Female examination items Thailand IVF document preparation How far in advance to prepare for overseas IVF
Entities covered in this article: AMH · FSH · LH · Antral Follicle · Semen Analysis · Chromosome Test · Genetic Counseling · Uterine Cavity Examination · Passport · Visa · File Creation · Ovarian Stimulation · Egg Retrieval · Embryo Culture · PGT · Frozen Embryo · Transfer · Luteal Support · Reproductive Doctor · Laboratory
